← Back to home

PATIENT IS NOT SUITABLE FOR COMPLETE SURGICAL RESECTION WITH A CYTOLOGICALLY OR HISTOLOGICALLY CONFIRMED SMALL CELL LUNG CANCER(SCLC)

Clinical trials for PATIENT IS NOT SUITABLE FOR COMPLETE SURGICAL RESECTION WITH A CYTOLOGICALLY OR HISTOLOGICALLY CONFIRMED SMALL CELL LUNG CANCER(SCLC) explained in plain language.

Never miss a new study

Get alerted when new PATIENT IS NOT SUITABLE FOR COMPLETE SURGICAL RESECTION WITH A CYTOLOGICALLY OR HISTOLOGICALLY CONFIRMED SMALL CELL LUNG CANCER(SCLC) trials appear

Sign up with your email to follow new studies for PATIENT IS NOT SUITABLE FOR COMPLETE SURGICAL RESECTION WITH A CYTOLOGICALLY OR HISTOLOGICALLY CONFIRMED SMALL CELL LUNG CANCER(SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat lung cancer? early trial tests novel drug

Disease control Recruiting now

This early-stage study is testing a new drug called SNB-101 in people with advanced small cell lung cancer that has worsened after standard treatment. The main goals are to find a safe dose, see how the body processes the drug, and check for any early signs that it might help con…

Matched conditions: PATIENT IS NOT SUITABLE FOR COMPLETE SURGICAL RESECTION WITH A CYTOLOGICALLY OR HISTOLOGICALLY CONFIRMED SMALL CELL LUNG CANCER(SCLC)

Phase: PHASE1, PHASE2 • Sponsor: SN BioScience • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

PATIENT IS NOT SUITABLE FOR COMPLETE SURGICAL RESECTION WITH A CYTOLOGICALLY OR HISTOLOGICALLY CONFIRMED SMALL CELL LUNG CANCER(SCLC)

Get alerted when new PATIENT IS NOT SUITABLE FOR COMPLETE SURGICAL RESECTION WITH A CYTOLOGICALLY OR HISTOLOGICALLY CONFIRMED SMALL CELL LUNG CANCER(SCLC) trials appear

New hope for Tough-to-Treat lung cancer? early trial tests novel drug